Abbott Laboratories Earnings

Abbott Laboratories’s revenue jumped 4.42% since last year same period to $11459Mn in the Q4 2025. On a quarterly growth basis, Abbott Laboratories has generated 0.79% jump in its revenue since last 3-months.

Abbott Laboratories’s net profit fell -80.76% since last year same period to $1776Mn in the Q4 2025. On a quarterly growth basis, Abbott Laboratories has generated 8.03% jump in its net profits since last 3-months.

Abbott Laboratories’s net profit margin fell -81.57% since last year same period to 15.5% in the Q4 2025. On a quarterly growth basis, Abbott Laboratories has generated 7.18% jump in its net profit margins since last 3-months.

Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.15 - a -22.82% fall from last quarter’s estimates.

Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.15.

Abbott Laboratories’s earning per share (EPS) jumped 11.94% since last year same period to 1.5 in the Q4 2025. This indicates that the Abbott Laboratories has generated 11.94% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Abbott Laboratories declared 0.59 dividend per share during the earnings announcement for Q4 2025.